Genes2Me Private Limited
↗Gurgaon, India
Genes2Me is a molecular diagnostics company based in India, established in 2016. The company specializes in providing a wide range of diagnostic solutions, including Point-of-Care (POC) testing, RT-PCR kits, rapid antigen/antibody tests, and Next-Generation Sequencing (NGS) clinical panels for oncology, infectious diseases, and genetic disorders.
With a "Bench to Bedside" approach, Genes2Me operates a NABL-accredited diagnostic lab and a state-of-the-art manufacturing facility in Manesar, India. The company focuses on developing innovative, cost-effective, and CE-IVD approved diagnostic tools to support personalized medicine and improve clinical outcomes in both routine pathology and advanced molecular diagnostics.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$2M-$3M
Founded:2016
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Molecular Diagnostics, NGS, RT-PCR
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Collaborates with various clinical labs and hospitals for the implementation of NGS and POC diagnostic platforms.
COMPETITION
Position:Niche Player
Competitors:Natera, LifeCell, Lantern Pharma, MedGenome, Mapmygenome
LEADERSHIP
Key Executives:
Neeraj Gupta - Founder & CEO
Scientific Founders:Neeraj Gupta
LINKS
Website:genes2me.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Genes2Me Private Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Genes2Me Private Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.